Stowers Institute For Medical Research

Stowers Institute For Medical Research, a tax-exempt nonprofit research organization headquartered in Kansas City, Missouri, receives federal grant funding as a prime recipient for fundamental biomedical research, with no federal contracts or contract vehicles in its footprint. The institute operates 91% of its recent awards as a prime recipient on National Institutes of Health project grants, with 9% flowing as subawards to partner universities; it does not compete on federal contracts, IDIQs, GWACs, or BPAs.

The institute's capability portfolio centers on developmental biology, molecular and cellular mechanisms of human congenital disorders, and aging-related research. Representative work includes a $124,200 National Institute of Dental and Craniofacial Research grant awarded September 1, 2026, investigating ribosome biogenesis regulation of neural crest cell differentiation in craniofacial development; an $886,687 National Science Foundation Division of Molecular and Cellular Biosciences award from July 15, 2026, defining molecular mechanisms of quality control during ribosome assembly and training undergraduate students in molecular biology; a $371,250 National Institute of Dental and Craniofacial Research award from March 1, 2026, examining pathogenesis and prevention of craniofacial anomalies; and a $429,000 National Institute of General Medical Sciences award from February 13, 2026, investigating maternal messenger RNA function during zebrafish embryogenesis using CRISPR-Cas13d systems. Additional research includes cancer-related genome integrity maintenance, reproductive aging mechanisms, protein phase transitions in neurodegenerative disease, and evolutionary developmental biology in reptile and fish model systems.

Customer concentration is sharply focused on health and life sciences research grants within the Department of Health and Human Services. The National Institutes of Health accounts for 20 awards across the portfolio; when broken down by institute, the National Institute of General Medical Sciences holds 16 awards, the National Institute of Child Health and Human Development holds 12, and the National Institute of Dental and Craniofacial Research holds 8. Together, these NIH component institutes and the broader NIH entity represent 70% of recent awards by count. The institute also receives funding from the National Science Foundation (Division of Molecular and Cellular Biosciences), the National Cancer Institute, and the National Institute on Aging — all aligned with academic research grant programs rather than federal procurement.

Eight awards carrying combined potential value across their project periods are scheduled to reach ultimate completion within the next twenty-four months, representing the recompete window for the institute's grant funding cycle. The institute acts as a subrecipient on collaborative research grants with Northwestern University, New York University, Children's Mercy Hospital, University of California, Arizona State University, and the University of Missouri System, providing specialized capabilities in zebrafish embryology, transgenic organism development, spatial transcriptomics, and CRISPR-based molecular tools.